OCTRI Pilot Project Awards 2017
Catalyst Pilot Awardees
Peter JacobsiPancreas: Internet based on-demand artificial pancreas app-generator to accelerate clinical trials research
Biomedical Innovation Program
The Biomedical Innovation Program (BIP) is designed to accelerate the movement of healthcare technologies from academia to the marketplace. In 2017, OCTRI will fund three collaborative, innovative pilot projects that address significant healthcare problems. The BIP is a collaboration between OCTRI and Technology Transfer & Business Development (TTBD), with additional funding and support from industry partners, Welch-Allyn, and GE Healthcare.
David HuangDry Eye Treatment Device
David SheridanWearable Monitoring for Mental Health Patients
David SimonsGlaucoma Tube Implant with Modulated Flow
Biomedical Innovation Program Drug Discovery
This track of BIP funding supports drug discovery platforms and early stage therapeutic technology projects, such as validation of drug targets, small molecules, vaccines, antibodies, and biologics. The BIP Drug Discovery program is a collaboration between OCTRI, Technology Transfer & Business Development (TTBD), and the OHSU Knight Cancer Institute.
Monika DavareDevelopment of a 'hit to lead' compound as a therapeutic agent to treat Ewing's sarcoma and subsets of hematological malignancies
Beth Habecker & Michael Cohen
Novel compositions targeting protein tyrosine phosphatase sigma for nerve regeneration